IL162749A0 - Transdifferentiation of pancreatic acinar cells - Google Patents

Transdifferentiation of pancreatic acinar cells

Info

Publication number
IL162749A0
IL162749A0 IL16274903A IL16274903A IL162749A0 IL 162749 A0 IL162749 A0 IL 162749A0 IL 16274903 A IL16274903 A IL 16274903A IL 16274903 A IL16274903 A IL 16274903A IL 162749 A0 IL162749 A0 IL 162749A0
Authority
IL
Israel
Prior art keywords
transdifferentiation
acinar cells
pancreatic acinar
pancreatic
cells
Prior art date
Application number
IL16274903A
Other languages
English (en)
Original Assignee
Univ Mcgill
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Mcgill filed Critical Univ Mcgill
Publication of IL162749A0 publication Critical patent/IL162749A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0676Pancreatic cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/48Drugs for disorders of the endocrine system of the pancreatic hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/48Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/998Proteins not provided for elsewhere

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
IL16274903A 2002-01-11 2003-01-10 Transdifferentiation of pancreatic acinar cells IL162749A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34689002P 2002-01-11 2002-01-11
PCT/CA2003/000013 WO2003057862A2 (en) 2002-01-11 2003-01-10 Transdifferentiation of pancreatic acinar cells

Publications (1)

Publication Number Publication Date
IL162749A0 true IL162749A0 (en) 2005-11-20

Family

ID=23361448

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16274903A IL162749A0 (en) 2002-01-11 2003-01-10 Transdifferentiation of pancreatic acinar cells

Country Status (20)

Country Link
US (1) US7662768B2 (no)
EP (1) EP1463801B1 (no)
JP (1) JP2005514426A (no)
KR (1) KR20040072680A (no)
CN (1) CN1610693A (no)
AR (1) AR038281A1 (no)
AT (1) ATE404661T1 (no)
AU (1) AU2003201553A1 (no)
BR (1) BR0306656A (no)
CA (1) CA2469052A1 (no)
DE (1) DE60322831D1 (no)
IL (1) IL162749A0 (no)
MA (1) MA27413A1 (no)
MX (1) MXPA04006385A (no)
NO (1) NO20042205L (no)
PE (1) PE20030744A1 (no)
PL (1) PL371260A1 (no)
RU (1) RU2004119417A (no)
TW (1) TW200302228A (no)
WO (1) WO2003057862A2 (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003275853A1 (en) * 2002-10-24 2004-05-13 Mcgill University Use of ingap for reversing diabetes
US20160039877A1 (en) 2013-03-15 2016-02-11 Shenzhen Hightide Biopharmaceutical, Ltd. Compositions and methods of using islet neogenesis peptides and analogs thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0815129B1 (en) * 1995-02-22 2011-01-05 Eastern Virginia Medical School of the Medical College of Hampton Roads Ingap protein involved in pancreatic islet neogenesis
US5834590A (en) * 1995-02-22 1998-11-10 Eastern Virginia Medical School Of The Medical College Of Hampton Roads Ingap protein involved in pancreatic islet neogenesis
CA2463914A1 (en) * 2001-10-18 2003-04-24 Ixion Biotechnology, Inc. Conversion of liver stem and progenitor cells to pancreatic functional cells

Also Published As

Publication number Publication date
PE20030744A1 (es) 2003-10-24
BR0306656A (pt) 2004-10-05
KR20040072680A (ko) 2004-08-18
CN1610693A (zh) 2005-04-27
US20030203850A1 (en) 2003-10-30
AU2003201553A1 (en) 2003-07-24
ATE404661T1 (de) 2008-08-15
AR038281A1 (es) 2005-01-12
NO20042205L (no) 2004-09-13
DE60322831D1 (de) 2008-09-25
EP1463801A2 (en) 2004-10-06
TW200302228A (en) 2003-08-01
MA27413A1 (fr) 2005-07-01
PL371260A1 (en) 2005-06-13
US7662768B2 (en) 2010-02-16
JP2005514426A (ja) 2005-05-19
WO2003057862A2 (en) 2003-07-17
RU2004119417A (ru) 2005-02-27
CA2469052A1 (en) 2003-07-17
EP1463801B1 (en) 2008-08-13
MXPA04006385A (es) 2004-10-04
WO2003057862A3 (en) 2003-10-02

Similar Documents

Publication Publication Date Title
EG23458A (en) Set of elements for assemlying structures
AU2003264939A8 (en) Watch
AU2003236991A8 (en) Representations of processes
HK1062202A1 (en) Watchcase
AU151175S (en) Watch case
IL162167A0 (en) Metabolites of (3-äÄ4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-aminoÜ-methylü-phenoxy)-acetic acid
AU151177S (en) Watch case
AU2003253918A8 (en) Methods of modifying behavior of cd9-expressing cells
AU151176S (en) Watch case
IL162749A0 (en) Transdifferentiation of pancreatic acinar cells
AU2003238013A8 (en) Detection of rna structural elements
TW531036U (en) Improved structure of push button
TW540808U (en) Improved structure of push button
AU149407S (en) Watch case
AU2003248634A8 (en) Maintenance of islet cells
TW524422U (en) Improved structure of card-inserting case
TW580105U (en) Improved structure of burner
AU2003264942A8 (en) Watch
EP1502162A4 (en) CLOCK
TW549334U (en) Improved structure of roller
TW589947U (en) Structure of rotatable buckle set
GB0200096D0 (en) Prestress of structural elements
GB0225016D0 (en) Secure watch
AU150954S (en) Set of lighters
AU150955S (en) Set of lighters